Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A Walmart-Humana deal targets pharmacy customers. Photos: Diego Herculano / NurPhoto and iStock via Getty Images

Walmart's potential buyout of Humana could be one of the most consequential deals in the feverish turf war of health care mergers, because it targets the spending power of the aging population.

The big picture: If a Walmart-Humana deal comes to fruition, which is still a big "if," Walmart would catapult from being the most recognizable American retailer into an even bigger corporate powerhouse with a tight grip on billions of federal health care dollars.

The details: Walmart could buy Humana, the Wall Street Journal reported, or the two companies could expand their current relationship.

Walmart and Humana already have a co-branded Medicare Part D plan, which covers prescription costs for people in the traditional Medicare program. More than 5.3 million people have a Humana drug plan, and membership has been growing like crazy as more Walmart shoppers sign up, the company said in its annual filing.

The impact: Many more major health care services would fall under Walmart and Humana's combined roof, including:

  • 3.5 million seniors and disabled people with private Humana Medicare Advantage plans.
  • Humana's pharmacy benefit manager, the fourth-largest in the country by filled prescriptions.
  • Home health services, thanks to Humana's pending acquisition of Kindred Healthcare.
  • Humana's Conviva health clinics.
  • 4,400 Walmart pharmacies.
  • PillPack would add more mail-order prescriptions if Walmart follows through on that rumored acquisition.

The bottom line: Seniors and low-income shoppers already are Walmart's core demographics. With Humana, Walmart could easily snag a piece of their their health care spending (which is heavily subsidized by taxpayers through Medicare and Medicaid), and boost food and retail sales in the process.

Keep in mind: Some of the most valuable retail customers are the people who pick up prescriptions.

  • Pharmacy customers spend almost four times more than people who only shop for groceries, according to investor documents posted by Albertsons, which is acquiring Rite Aid pharmacies.
  • Pharmacy customers visit a store 2.3 times per week compared with less than once a week for regular shoppers.
  • A Walmart-Humana deal would "preserve the pharmacy volume (and subsequent incremental spend inside the store)," according to financial analysts with Barclays.

Looking ahead: The two other major mega-mergers, CVS-Aetna and Cigna-Express Scripts, similarly consolidate the prescription drug market.

Go deeper

Updated 4 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Health: The good and bad news about antibody therapies — Fauci: Hotspots have materialized across "the entire country."
  2. World: Belgium imposes lockdown, citing "health emergency" due to influx of cases.
  3. Economy: Conference Board predicts economy won’t fully recover until late 2021.
  4. Education: Surge threatens to shut classrooms down again.
  5. Technology: The pandemic isn't slowing tech.
  6. Travel: CDC replaces COVID-19 cruise ban with less restrictive "conditional sailing order."
  7. Sports: High school football's pandemic struggles.
  8. 🎧Podcast: The vaccine race turns toward nationalism.
Dan Primack, author of Pro Rata
Updated 4 hours ago - Economy & Business

Dunkin' Brands agrees to $11B Inspire Brands sale

Photo: Alexi Rosenfeld/Getty Images

Dunkin' Brands, operator of both Dunkin' Donuts and Baskin-Robbins, agreed on Friday to be taken private for nearly $11.3 billion, including debt, by Inspire Brands, a restaurant platform sponsored by private equity firm Roark Capital.

Why it matters: Buying Dunkin’ will more than double Inspire’s footprint, making it one of the biggest restaurant deals in the past 10 years. This could ultimately set up an IPO for Inspire, which already owns Arby's, Jimmy John's and Buffalo Wild Wings.

Ina Fried, author of Login
6 hours ago - Technology

Federal judge halts Trump administration limit on TikTok

Illustration: Aïda Amer/Axios

A federal judge on Friday issued an injunction preventing the Trump administration from imposing limits on the distribution of TikTok, Bloomberg reports. The injunction request came as part of a suit brought by creators who make a living on the video service.

Why it matters: The administration has been seeking to force a sale of, or block, the Chinese-owned service. It also moved to ban the service from operating in the U.S. as of Nov. 12, a move which was put on hold by Friday's injunction.